miRNA mimetics (Asuragen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamemiRNA mimetics (Asuragen)
Drug Alias NamemiR-215 mimetic (Asuragen)miR-Rx01 mimetic (Asuragen)miR-Rx02 mimetic (Asuragen)miR-Rx07 mimetic (Asuragen)microRNA mimetics (Asuragen) +[17] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsuragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsuragen IncMirna Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsLung NeoplasmsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A